Orpheus Bioscience
Founded Year
2016Stage
Unattributed - II | AliveTotal Raised
$4.42MLast Raised
$3.16M | 3 yrs agoAbout Orpheus Bioscience
Orpheus Bioscience focuses on the development of treatments for autoimmune diseases. In pursuit of this goal, the company develops the PantId, a protein-based therapeutic for the elimination of pathological immune cells and antibodies from patients. PantIds are specifically designed for each autoimmune disease, resulting in a product with fewer adverse effects than conventional immunosuppressive therapeutics.
Orpheus Bioscience Headquarter Location
9385 Discovery Blvd. Suite 115
Manassas, Virginia, 20109,
United States
212-692-6758
Expert Collections containing Orpheus Bioscience
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Orpheus Bioscience is included in 1 Expert Collection, including Biopharma Tech.
Biopharma Tech
5,241 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Orpheus Bioscience Patents
Orpheus Bioscience has filed 1 patent.
The 3 most popular patent topics include:
- Autoimmune diseases
- Clusters of differentiation
- Immune system
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
3/23/2018 | Immunology, Immune system, Clusters of differentiation, T cells, Autoimmune diseases | Application |
Application Date | 3/23/2018 |
|---|---|
Grant Date | |
Title | |
Related Topics | Immunology, Immune system, Clusters of differentiation, T cells, Autoimmune diseases |
Status | Application |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.